Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

about

Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists.Pharmacokinetic drug evaluation of extended release lorcaserin for the treatment of obesity.Centrally Acting Agents for Obesity: Past, Present, and Future

P2860

Q47588598-9A72C7A4-245D-4A8D-9B63-FE0E70D8B398 Q47849415-0F58BF7A-A4E6-43C6-8CE7-1BBC0033E7A6 Q57177981-05AB930B-861D-459B-BC36-920CAD82C61A

P2860

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

Item

http://www.wikidata.org/entity/Q39152644

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

@en

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

@nl

type

Item

label

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

@en

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

@nl

prefLabel

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

@en

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

@nl

P1476

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials

@en

P2093

Nancy Hall

http://www.w3.org/2001/XMLSchema#string

Neil J Weissman

http://www.w3.org/2001/XMLSchema#string

Randi Fain

http://www.w3.org/2001/XMLSchema#string

Steven R Smith

http://www.w3.org/2001/XMLSchema#string

William R Shanahan

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of valvular heart disease associated with use of fenfluramine

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies

Valvular heart disease associated with fenfluramine-phentermine

Drugs and valvular heart disease

Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine

Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine

Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities

The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.

Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

P304

39-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/OBY.21695

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27888609

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

6680283

http://www.w3.org/2001/XMLSchema#string

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

about

P2860

P2860

Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932